Stay updated on Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a minor deployment/build update for the page. This change does not affect study information or how it is presented to users.
    Difference
    0.1%
    Check dated 2026-07-04T08:22:34.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays a newer revision tag (v3.6.2) replacing the previous v3.6.0, indicating a small asset-level update to the page.
    Difference
    0.1%
    Check dated 2026-06-27T05:59:21.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page adds new help/navigation sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading, removing the prior Intervention / Treatment label and the v3.5.5 revision reference; the revision note now shows Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T00:30:31.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a new revision tag (Revision: v3.5.5) replacing the previous v3.5.4. This reflects a software or template update rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-05T16:13:30.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:06.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s displayed revision number was updated from v3.5.2 to v3.5.3, indicating a minor platform/release change without altering the study record.
    Difference
    0.1%
    Check dated 2026-04-24T06:37:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.